Esmolol Hydrochloride

Cysolvia® is one of brands under Miedykol® a high-end and certified active pharmaceutical ingredients (APIs) and pharmaceutical intermediates manufacturer in China, mainly providing various APIs products and customized production (CMO/CDMO). We produce the esmolol hydrochloride products which was developed earlist by Baxter Healthcare Corporation and approved in multiple countries. It is known as a cardioselective beta-adrenergic blocker that plays an effective role in the short-term control of ventricular rate and heart rate in different types of tachycardia, including perioperative tachycardia and hypertension. Its mechanism of action is its increasing of atrioventricular refractory time and decreasing of oxygen demand of the myocardium. At Miedykol, we produce the innovative and market much-needed active ingredient products for special disease drugs managing arrhythmia, convulsion, postmenopausal osteoporosis, etc.. We also support your healthcare project and clinical therapies with the tailored production and integrative preparation solutions. Reach out to us for further information.